Bayer Statement in Response to Ruling on Monsanto’s Motion to Reverse Bifurcate in MDL
The following is Bayer’s statement regarding a ruling by Judge Vince Chhabria to reverse bifurcate in the In re: Roundup Products Liability Litigation in the U.S. District Court for the Northern District of California. The following is Bayer’s statement regarding a ruling [link to order] by Judge Vince Chhabria to reverse bifurcate in the In re: Roundup Products Liability Litigation in the U.S. District Court for the Northern District of California. The following is Bayer’s statement regarding a ruling [link to order] by Judge Vince Chhabria to reverse bifurcate in the In re: Roundup Products Liability Litigation in the U.S. District Court for the Northern District of California.
“The Court’s decision to keep the focus of the trial on the extensive science relevant to human health is encouraging. Bayer is confident that this science demonstrates our glyphosate-based herbicides are safe for use and believes it will ultimately be determinative in this litigation.”
“Glyphosate-based herbicides have been used safely and successfully for over four decades worldwide and are a valuable tool to help farmers deliver crops to markets and practice sustainable farming by reducing soil tillage, soil erosion and carbon emissions. There is an extensive body of research on glyphosate and glyphosate-based herbicides, including more than 800 rigorous studies submitted to EPA, European and other regulators in connection with the registration process, that confirms that these products are safe when used as directed. Notably, the largest and most recent epidemiologic study – the 2018 independent National Cancer Institute-supported long-term study that followed over 50,000 pesticide applicators for more than 20 years and was published after the IARC monograph – found no association between glyphosate-based herbicides and cancer. Additionally, EPA’s 2017 post-IARC cancer risk assessment examined more than 100 studies the agency considered relevant and concluded that glyphosate is ‘not likely to be carcinogenic to humans,’ its most favorable rating.”